Profile | GDS5420 / 201050_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 505.01 | 67 |
GSM1296119 | B_lesional_pre-dose | 324.23 | 60 |
GSM1296076 | C_lesional_pre-dose | 176.7 | 52 |
GSM1296092 | D_lesional_pre-dose | 294.34 | 60 |
GSM1296103 | E_lesional_pre-dose | 707.8 | 73 |
GSM1296078 | F_lesional_pre-dose | 136.98 | 48 |
GSM1296107 | G_lesional_pre-dose | 343.79 | 61 |
GSM1296109 | H_lesional_pre-dose | 525.42 | 68 |
GSM1296080 | I_lesional_pre-dose | 304.11 | 60 |
GSM1296090 | J_lesional_pre-dose | 401.49 | 65 |
GSM1296074 | K_lesional_pre-dose | 145.63 | 50 |
GSM1296111 | L_lesional_pre-dose | 366.76 | 62 |
GSM1296099 | M_lesional_pre-dose | 509.08 | 68 |
GSM1296086 | O_lesional_pre-dose | 250.9 | 57 |
GSM1296117 | P_lesional_pre-dose | 283.48 | 58 |
GSM1296113 | Q_lesional_pre-dose | 363.48 | 62 |
GSM1296096 | R_lesional_pre-dose | 677.64 | 73 |
GSM1296105 | S_lesional_pre-dose | 511.88 | 68 |
GSM1296098 | T_lesional_pre-dose | 516.55 | 68 |
GSM1296101 | U_lesional_pre-dose | 696.3 | 73 |
GSM1296121 | V_lesional_pre-dose | 299.09 | 59 |
GSM1296088 | W_lesional_pre-dose | 264.45 | 57 |
GSM1296082 | X_lesional_pre-dose | 233.55 | 56 |
GSM1296115 | Y_lesional_pre-dose | 368.54 | 62 |
GSM1296084 | Z_lesional_pre-dose | 355.84 | 62 |
GSM1296072 | B_lesional_day8 | 319.2 | 60 |
GSM1296069 | L_lesional_day8 | 544.07 | 69 |
GSM1296071 | P_lesional_day8 | 472.12 | 66 |
GSM1296070 | Y_lesional_day8 | 482.67 | 67 |
GSM1296073 | V_lesional_day8 | 300.34 | 60 |
GSM1296034 | A_lesional_day15 | 754.67 | 74 |
GSM1296041 | G_lesional_day15 | 345.72 | 62 |
GSM1296035 | R_lesional_day15 | 851.52 | 76 |
GSM1296038 | U_lesional_day15 | 592.56 | 71 |
GSM1296047 | B_lesional_day15 | 298.91 | 58 |
GSM1296039 | E_lesional_day15 | 451.74 | 66 |
GSM1296042 | H_lesional_day15 | 392.81 | 63 |
GSM1296043 | L_lesional_day15 | 431.72 | 65 |
GSM1296037 | M_lesional_day15 | 753.54 | 75 |
GSM1296046 | P_lesional_day15 | 379.15 | 62 |
GSM1296044 | Q_lesional_day15 | 368.43 | 61 |
GSM1296045 | Y_lesional_day15 | 676.53 | 73 |
GSM1296025 | C_lesional_day15 | 219.78 | 54 |
GSM1296033 | D_lesional_day15 | 307.25 | 59 |
GSM1296027 | I_lesional_day15 | 160.55 | 51 |
GSM1296032 | J_lesional_day15 | 301.15 | 59 |
GSM1296024 | K_lesional_day15 | 232.51 | 55 |
GSM1296031 | W_lesional_day15 | 535.33 | 68 |
GSM1296028 | X_lesional_day15 | 287.84 | 58 |
GSM1296029 | Z_lesional_day15 | 370.04 | 62 |
GSM1296026 | F_lesional_day15 | 295.29 | 60 |
GSM1296030 | O_lesional_day15 | 185.11 | 53 |
GSM1296040 | S_lesional_day15 | 765.37 | 75 |
GSM1296036 | T_lesional_day15 | 465.61 | 66 |
GSM1296048 | V_lesional_day15 | 426.62 | 65 |
GSM1296059 | A_lesional_day43 | 782.21 | 75 |
GSM1296066 | G_lesional_day43 | 328.78 | 60 |
GSM1296060 | R_lesional_day43 | 592.66 | 70 |
GSM1296063 | U_lesional_day43 | 525.79 | 69 |
GSM1296064 | E_lesional_day43 | 453.61 | 67 |
GSM1296067 | H_lesional_day43 | 423.09 | 64 |
GSM1296062 | M_lesional_day43 | 509.04 | 67 |
GSM1296068 | Q_lesional_day43 | 361.34 | 61 |
GSM1296050 | C_lesional_day43 | 188.19 | 52 |
GSM1296057 | D_lesional_day43 | 616.19 | 71 |
GSM1296052 | I_lesional_day43 | 183.03 | 52 |
GSM1296054 | J_lesional_day43 | 321.34 | 59 |
GSM1296049 | K_lesional_day43 | 183.12 | 51 |
GSM1296055 | W_lesional_day43 | 1298.7 | 83 |
GSM1296053 | X_lesional_day43 | 290.35 | 58 |
GSM1296058 | Z_lesional_day43 | 1123.29 | 81 |
GSM1296051 | F_lesional_day43 | 205.93 | 54 |
GSM1296056 | O_lesional_day43 | 640.74 | 72 |
GSM1296065 | S_lesional_day43 | 464.12 | 66 |
GSM1296061 | T_lesional_day43 | 472.92 | 66 |
GSM1296095 | A_non-lesional_pre-dose | 497.37 | 68 |
GSM1296120 | B_non-lesional_pre-dose | 339.42 | 61 |
GSM1296077 | C_non-lesional_pre-dose | 270.19 | 58 |
GSM1296093 | D_non-lesional_pre-dose | 439.4 | 65 |
GSM1296104 | E_non-lesional_pre-dose | 678.01 | 73 |
GSM1296079 | F_non-lesional_pre-dose | 199.2 | 53 |
GSM1296108 | G_non-lesional_pre-dose | 401.09 | 64 |
GSM1296110 | H_non-lesional_pre-dose | 456.98 | 65 |
GSM1296081 | I_non-lesional_pre-dose | 305.67 | 60 |
GSM1296091 | J_non-lesional_pre-dose | 252.45 | 57 |
GSM1296075 | K_non-lesional_pre-dose | 215.8 | 55 |
GSM1296112 | L_non-lesional_pre-dose | 413.8 | 64 |
GSM1296100 | M_non-lesional_pre-dose | 861.35 | 77 |
GSM1296087 | O_non-lesional_pre-dose | 161.23 | 51 |
GSM1296118 | P_non-lesional_pre-dose | 344.12 | 60 |
GSM1296114 | Q_non-lesional_pre-dose | 302.03 | 58 |
GSM1296097 | R_non-lesional_pre-dose | 686.34 | 73 |
GSM1296106 | S_non-lesional_pre-dose | 544.94 | 69 |
GSM1296102 | U_non-lesional_pre-dose | 787.85 | 75 |
GSM1296122 | V_non-lesional_pre-dose | 395.59 | 63 |
GSM1296089 | W_non-lesional_pre-dose | 399.27 | 63 |
GSM1296083 | X_non-lesional_pre-dose | 359.23 | 62 |
GSM1296116 | Y_non-lesional_pre-dose | 327.11 | 59 |
GSM1296085 | Z_non-lesional_pre-dose | 306.86 | 59 |